Bromacil | |
| |
Formula | C9H13BrN2O2 |
Structure | |
Description | Colorless to white odorless crystalline solid. Commercially available as a wettable powder or in liquid formulations. |
Uses | Herbicide. |
Registry Numbers and Inventories. | |
CAS | 314-40-9 |
EC (EINECS/ELINCS) | 206-245-1 |
RTECS | YQ9100000 |
RTECS class | Agricultural Chemical and Pesticide; Mutagen; Reproductive Effector |
Merck | 12,1402 |
Beilstein/Gmelin | 647896 |
Beilstein Reference | 5-24-07-00040 |
EPA OPP | 12301 |
Swiss Giftliste 1 | G-4479 |
Canada DSL/NDSL | DSL |
Austrailia AICS | Listed |
New Zealand | Listed |
Japan ENCS (MITI) | Listed |
Korea ECL | Listed |
Properties. | |
Formula | C9H13BrN2O2 |
Formula mass | 261.12 |
Melting point, °C | 158 - 159 |
Boiling point, °C | 411 |
Vapor pressure, mmHg | 3E-7 |
Density | 1.55 g/cm3 (20 C) |
Solubility in water | 800 mg/L |
pKa/pKb | 9.30 (pKa) |
Partition coefficient, pKow | 2.11 |
Hazards and Protection. | |
Storage | Store in cool, dry place. Exposure of water-soluble formulations to air can cause some loss of water solubility. |
Handling | All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood. |
Protection | Wear appropriate personal protective clothing to prevent skin contact. |
Respirators | Use NIOSH/MSHA approved respirator appropriate for exposure of concern. |
Small spills/leaks | Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces. |
Stability | Stable up to MP and slowly sublimes @ temperature just below its MP active ingredient is chemically stable under normal storage conditions stable in aqueous bases. Slowly decomposed by concentrated acids. |
Incompatibilities | Strong oxidizing agents. |
Decomposition | When heated to decomposition it emits very toxic fumes of hydrogen bromide and nitrogen oxides. |
Fire. | ||||
Fire fighting | Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire. | |||
Fire potential | Active ingredient and dry formulations are non-flammable; the liquid formulation (hyvar-xl) is a combustible mixture which should be kept away from heat and open flame. |
Health. | |
Exposure limit(s) | NIOSH REL: TWA 1 ppm (10 mg/m3) |
Poison_Class | 4 |
Exposure effects | |
Ingestion | Nausea, vomiting, and diarrhea may be noted following ingestion. |
Inhalation | Symptoms: irritation eyes, skin, upper respiratory system; in animals: thyroid injury Target Organs: Eyes, skin, respiratory system, thyroid. |
Skin | Cyanosis unresponsive to oxygen therapy may be noted in patients with methemoglobinemia due to absorption of excessive amounts of these agents. |
Eyes | See inhalation. |
First aid |
|
Ingestion | Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended. |
Inhalation | If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention. |
Skin | Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists. |
Eyes | Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility. |
Transport. |